Pediatrics

New Insulin Glargine Approved; Late Dinner Bad for the Waistline?



(MedPage Today) — Mylan’s insulin glargine injection (Semglee, 100 units/mL) won full FDA approval for glycemic control in adult and pediatric patients with type 1 diabetes, as well as adults with type 2 diabetes.
The FDA listed more recalls…

Source link

Related posts

Most Primary Care Providers Screening Toddlers for Autism

Newsemia

Impact of a Prospective Audit and Feedback Antimicrobial Stewardship Program in Pediatric Units in Tertiary Care Teaching Hospital in Thailand

Newsemia

CDC: Coverage 94.7 Percent for Two Doses of MMR in 2018 to 2019

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World